{
  "id": 20754895,
  "title": "STAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and more",
  "url": "https://urgent.news/2026/11/19/stat-pharmalittle-were-reading-about-a-merck-ai-deal-china-and-the",
  "topic": "tech",
  "section": "Tech",
  "published": "2026-11-19T13:36:33.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/pharmalot/2026/11/19/merck-isomorphic-ai-deal-china-pharmaceutical-supply-chain/"
  },
  "original_language": "en",
  "account": "Merck and Isomorphic Labs, a cutting-edge AI drug designer, have announced a research collaboration to discover potential small molecule candidates for a significant oncology target, according to STAT. This partnership, the latest in a series between a pharmaceutical giant and Isomorphic, aims to leverage Isomorphic's advanced drug design engine alongside Merck's existing wet lab data, focusing on preclinical and clinical development, manufacturing, and commercialization of any resulting products. The U.S. Food and Drug Administration recently approved Sanofi's drug Infilbray, marking the first treatment for a rare genetic condition known as type 3 Gaucher disease. This disorder, primarily affecting the brain and nervous system, causes the accumulation of fatty substances within the body and brain. The FDA's approval was contingent on a late-stage study involving 43 patients aged 12 and above, who had already experienced stabilized symptoms outside the brain and nervous system through enzyme replacement therapy.",
  "summary": "Merck is entering a research collaboration with Isomorphic Labs, the AI drug designer built on a Nobel-winning technology",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "Merck inks cancer research deal with AI drug discovery firm Isomorphic Labs",
        "url": "https://urgent.news/2026/11/19/merck-inks-cancer-research-deal-with-ai-drug-discovery-firm",
        "published": "2026-11-19T13:18:29.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}